Skip to main content

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Stifel 2023 Healthcare Conference
Fireside Chat: Tuesday, November 14, 2023 at 3:35 pm ET
Location: Lotte New York Palace Hotel, New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

6th Annual Evercore ISI HealthCONx Conference
Fireside Chat: Wednesday, November 29, 2023 at 3:00 pm ET
Location: Kimpton EPIC Hotel, Miami, FL

Piper Sandler 35th Annual Healthcare Conference
Fireside Chat: Thursday, November 30, 2023 at 2:00 pm ET
Location: Lotte New York Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.15
-0.64 (-0.31%)
AAPL  261.81
-2.54 (-0.96%)
AMD  200.89
+0.77 (0.38%)
BAC  52.25
-1.11 (-2.08%)
GOOG  304.80
+0.86 (0.28%)
META  645.43
+2.21 (0.34%)
MSFT  398.29
-1.31 (-0.33%)
NVDA  186.29
-1.69 (-0.90%)
ORCL  157.04
+0.87 (0.56%)
TSLA  409.95
-1.37 (-0.33%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.